Merck Sees 2005 Profit Hurt by Vioxx
14948
Merck & Co. Inc.MRK.N, reeling from  the recent withdrawal of its Vioxx arthritis drug, said  Wednesday it expects 2005 earnings of $2.42 to $2.52 a share --  a decline from expected 2004 results.
106270
A review of Merck's handling of Vioxx suggests that actions the company took - and did not take - may have affected the health of potentially thousands of patients.
408847
Merck posted a $1.63 billion fourth-quarter loss on Wednesday as  charges for its Vioxx litigation settlement dragged down results and share prices.
709583
A New Jersey jury on Monday ordered Merck & Co.  to pay $27.5 million in punitive damages after finding that the drugmaker was willful and reckless in promoting arthritis medicine Vioxx, which has since been withdrawn.
339141
Merck can&#39;t expect any immediate relief from the medicine that was supposed to replace Vioxx, the pain medication it took off the market.
63892
NEW YORK - Investors sent stocks mostly lower Thursday after Merck & Co. said it would be forced to remove one of its best-selling arthritis drugs from the market due to serious health risks...
695075
The U.S. Dow Jones Industrial average declined on Thursday after drug maker Merck & Co. recalled its widely sold Vioxx painkiller and its stock sunk 27 percent.
575614
Merck and Schering report bad news, but how much will it affect sales?
468942
Merck & Co. MRK.N on Thursday said  its quarterly profit fell 28 percent due to last month's recall  of its Vioxx arthritis drug, and the company predicted 2004  earnings will fall as much as 11 percent because of the recall.
93237
Merck & Co. Inc. MRK.N, reeling from  the recent withdrawal of its Vioxx arthritis drug, on Wednesday  said 2005 earnings will decline to levels below Wall Street  expectations, the third straight year of lower results.
714968
Merck &amp; Co. Inc. (MRK.N: Quote, Profile, Research) , whose earnings are being hurt by the withdrawal of its arthritis drug Vioxx, said on Tuesday it has increased the number of jobs to be cut by year-end to 5,100 from 4,400.
385466
Merck & Co Inc. on Thursday pulled its  arthritis drug Vioxx off the market because it increases the  risk of heart attack and stroke, a move that sent the company's  shares plunging, erasing $25 billion of its market value.
375780
Merck &amp; Co. said it&#39;s withdrawing its Vioxx painkiller, which generated $2.5 billion in worldwide sales last year, because of data showing an increased risk of heart attack and stroke.
102650
Drugs giant Merck & Co. which pulled its blockbuster painkiller Vioxx from shelves in September, is about to become the target of hundreds of plaintiffs' lawyers, the New York Times reported on Friday.
361813
The Wall Street Journal has reported that pharmaceutical company Merck knew as far back as 2000 that its arthritis medication, Vioxx, was linked to an increased risk of heart attack.
258313
Merck (nyse: MRK - news - people ) will conduct its annual analyst meeting tomorrow. The drug company is expected to provide information regarding liabilities for potential Vioxx-related lawsuits.
552579
Company earned 60 cents a share, down from 83 cents a year earlier; Vioxx linked to heart attacks. NEW YORK  - Merck &amp; Co.